PL3946322T3 - Sposoby przywracania wrażliwości na ttfields w komórkach nowotworowych opornych wobec ttfields, z inhibitorami ptger3 - Google Patents
Sposoby przywracania wrażliwości na ttfields w komórkach nowotworowych opornych wobec ttfields, z inhibitorami ptger3Info
- Publication number
- PL3946322T3 PL3946322T3 PL20717971.4T PL20717971T PL3946322T3 PL 3946322 T3 PL3946322 T3 PL 3946322T3 PL 20717971 T PL20717971 T PL 20717971T PL 3946322 T3 PL3946322 T3 PL 3946322T3
- Authority
- PL
- Poland
- Prior art keywords
- ttfields
- ptger3
- inhibitors
- methods
- cancer cells
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/205—Applying electric currents by contact electrodes continuous direct currents for promoting a biological process
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Radiology & Medical Imaging (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Electrotherapy Devices (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962826078P | 2019-03-29 | 2019-03-29 | |
| US201962849535P | 2019-05-17 | 2019-05-17 | |
| PCT/IB2020/052959 WO2020201967A1 (en) | 2019-03-29 | 2020-03-27 | Methods for restoring sensitivity to ttfields in ttfields-resistant cancer cells with ptger3 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3946322T3 true PL3946322T3 (pl) | 2024-02-26 |
Family
ID=70228406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20717971.4T PL3946322T3 (pl) | 2019-03-29 | 2020-03-27 | Sposoby przywracania wrażliwości na ttfields w komórkach nowotworowych opornych wobec ttfields, z inhibitorami ptger3 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11911610B2 (pl) |
| EP (3) | EP3988099B1 (pl) |
| JP (2) | JP7419391B2 (pl) |
| CN (1) | CN113613651B (pl) |
| DK (1) | DK3946322T3 (pl) |
| PL (1) | PL3946322T3 (pl) |
| WO (1) | WO2020201967A1 (pl) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10779875B2 (en) | 2013-05-06 | 2020-09-22 | Novocure Gmbh | Optimizing treatment using TTfields by changing the frequency during the course of long term tumor treatment |
| US10188851B2 (en) | 2015-10-28 | 2019-01-29 | Novocure Limited | TTField treatment with optimization of electrode positions on the head based on MRI-based conductivity measurements |
| US10821283B2 (en) | 2016-04-04 | 2020-11-03 | Novocure Gmbh | Reducing motility of cancer cells using tumor treating fields (TTFields) |
| WO2018134733A1 (en) | 2017-01-19 | 2018-07-26 | Moshe Giladi | System for viewing cell cultures under a microscope whilst applying ttfields |
| US11986647B2 (en) | 2018-09-07 | 2024-05-21 | Novocure Gmbh | Treating autoinflammatory and mitochondrial diseases using an alternating electric field |
| CN118925056A (zh) | 2018-10-15 | 2024-11-12 | 诺沃库勒有限责任公司 | 生成遍及大脑具有高均匀性的肿瘤治疗场（ttfields） |
| US11369790B2 (en) | 2018-10-25 | 2022-06-28 | Novocure Gmbh | Delivering alternating electric fields (e.g., TTFields) to a subject's spinal anatomy |
| KR102747887B1 (ko) | 2018-11-19 | 2024-12-27 | 노보큐어 게엠베하 | 선택적으로 주소 지정 가능한 하위 요소를 하지는 종양 치료장 제공을 위한 어레이 |
| SG11202101810SA (en) | 2018-11-29 | 2021-03-30 | Novocure Gmbh | Enhanced-flexibility transducer arrays for delivering ttfields (tumor treating fields) |
| CN113330485B (zh) | 2019-01-08 | 2025-09-26 | 诺沃库勒有限责任公司 | 评估将图像分割成不同类型组织的质量，用于使用肿瘤治疗场（TTField）来计划治疗 |
| CN114364432B (zh) | 2019-07-31 | 2025-10-31 | 诺沃库勒有限责任公司 | 经由埋入颅骨植入物中的电极施加肿瘤治疗场（TTField） |
| US12343336B2 (en) | 2019-08-05 | 2025-07-01 | Novocure Gmbh | Increasing cancer cells' sensitivity to tumor treating fields (TTFields) by inhibiting IL11 activity |
| US11890467B2 (en) | 2019-08-30 | 2024-02-06 | Novocure Gmbh | Delivering tumor treating fields (TTFields) to the neck |
| DK4074367T3 (da) | 2019-12-31 | 2023-05-22 | Novocure Gmbh | Arrays til levering af tumorbehandlingsfelter (tt-felter) med individuelt tilgængelige elektrodeelementer og temperatursensorer |
| CA3163315A1 (en) | 2019-12-31 | 2021-07-08 | Novocure Gmbh | High voltage, high efficiency sine wave generator that prevents spikes during amplitude adjustments and switching of channels |
| US12121739B2 (en) | 2019-12-31 | 2024-10-22 | Novocure Gmbh | Methods, systems, and apparatuses for managing temperatures induced by alternating fields |
| US20210299440A1 (en) | 2020-03-30 | 2021-09-30 | Novocure Gmbh | Intravenous / Intra-Spinal / Intra-Cavity / Intraventricular Delivery of TTFields (Tumor Treating Fields) for Treating Cancer and Metastases |
| WO2021214693A1 (en) | 2020-04-24 | 2021-10-28 | Novocure Gmbh | Using alternating electric fields to increase permeability of the blood brain barrier |
| US11818943B2 (en) | 2020-06-25 | 2023-11-14 | Novocure Gmbh | Fabricating organic light emitting diodes (OLEDs) using tubulin |
| EP4223364B1 (en) | 2020-09-25 | 2024-04-24 | Novocure GmbH | Varying the metallization area on individual electrode elements in a tumor treating fields system to maximize current without overheating |
| US20220267445A1 (en) * | 2021-02-17 | 2022-08-25 | Novocure Gmbh | Methods and Compositions for Determining Susceptibility to Treatment with Checkpoint Inhibitors |
| US20250101406A1 (en) | 2022-09-23 | 2025-03-27 | Novocure Gmbh | 3d models for predicting treatment responses to alternating electric fields |
| TW202528013A (zh) | 2023-09-29 | 2025-07-16 | 瑞士商諾沃庫勒有限責任公司 | 使用振幅和頻率的交錯變化來改善交變電場治療期間的電感覺 |
| WO2026003783A1 (en) * | 2024-06-27 | 2026-01-02 | Novocure Gmbh | Compositions, systems, and methods for treating cancer using tumor treating fields (ttfields) and nf-κb inhibitors |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5280600B2 (ja) | 2000-02-17 | 2013-09-04 | パルティ、ヨーラム | 分裂中の細胞を破壊するための方法および装置 |
| US7089054B2 (en) | 2002-10-02 | 2006-08-08 | Standen Ltd. | Apparatus and method for treating a tumor or the like |
| US7136699B2 (en) | 2002-10-02 | 2006-11-14 | Standen, Ltd. | Apparatus for destroying dividing cells |
| US6868289B2 (en) | 2002-10-02 | 2005-03-15 | Standen Ltd. | Apparatus for treating a tumor or the like and articles incorporating the apparatus for treatment of the tumor |
| US8447395B2 (en) | 2000-02-17 | 2013-05-21 | Novocure Ltd | Treating bacteria with electric fields |
| US8175698B2 (en) | 2000-02-17 | 2012-05-08 | Novocure Ltd. | Treating bacteria with electric fields |
| US7016725B2 (en) | 2001-11-06 | 2006-03-21 | Standen Ltd. | Method and apparatus for destroying dividing cells |
| US7599746B2 (en) | 2000-02-17 | 2009-10-06 | Standen Ltd | Apparatus and method for preventing the spread of cancerous metastases and for elimination of metastases |
| JP4750784B2 (ja) | 2004-04-23 | 2011-08-17 | ノヴォキュアー・リミテッド | 異なる周波数の電界による腫瘍等の治療 |
| WO2006061688A1 (en) | 2004-12-07 | 2006-06-15 | Standen Ltd. | Electrodes for applying an electric field in-vivo over an extended period of time |
| JP5559460B2 (ja) | 2004-12-27 | 2014-07-23 | スタンデン・リミテッド | 異なる配向の電界を用いて腫瘍またはその類似物を処理する方法 |
| DK1933937T3 (en) | 2005-10-03 | 2015-04-07 | Novocure Ltd | OPTIMIZATION OF THE CHARACTERISTICS OF AN ELECTRIC FIELD FOR ENHANCING FIELD EFFECT ON proliferating cells |
| US8019414B2 (en) | 2006-04-05 | 2011-09-13 | Novocure Ltd. | Treating cancer using electromagnetic fields in combination with other treatment regimens |
| US20100074896A1 (en) | 2006-11-30 | 2010-03-25 | The Johns Hopkins University | Antagonists of pge2 ep3 receptors |
| US8465533B2 (en) | 2007-03-06 | 2013-06-18 | Novocure Limited | Treating cancer using electromagnetic fields in combination with photodynamic therapy |
| EP2183024B1 (en) | 2007-08-14 | 2019-05-15 | Novocure Ltd. | Treating parasites with electric fields |
| US8715203B2 (en) | 2007-09-17 | 2014-05-06 | Novocure Limited | Composite electrode |
| ES2628580T3 (es) * | 2009-04-06 | 2017-08-03 | Otsuka Pharmaceutical Co., Ltd. | Combinación de decitabina con inhibidor de citidina deaminasa y uso del mismo en el tratamiento de cáncer el tratamiento de cáncer |
| US9381176B2 (en) | 2012-02-24 | 2016-07-05 | Wisconsin Alumni Research Foundation | E-prostanoid receptor, Ptger3, as a novel anti-diabetic therapeutic target |
| US9655669B2 (en) | 2013-05-06 | 2017-05-23 | Novocure Limited | Optimizing treatment using TTFields by changing the frequency during the course of long term tumor treatment |
| US10779875B2 (en) | 2013-05-06 | 2020-09-22 | Novocure Gmbh | Optimizing treatment using TTfields by changing the frequency during the course of long term tumor treatment |
| US20190117963A1 (en) | 2014-07-25 | 2019-04-25 | Loyalty Based Innovations, LLC | Apparatus and method for treating multiple tumors in patients with metastatic disease by electric fields |
| US9910453B2 (en) | 2015-09-25 | 2018-03-06 | Novocure Limited | High voltage, high efficiency sine wave generator with pre-set frequency and adjustable amplitude |
| US10188851B2 (en) | 2015-10-28 | 2019-01-29 | Novocure Limited | TTField treatment with optimization of electrode positions on the head based on MRI-based conductivity measurements |
| US10821283B2 (en) | 2016-04-04 | 2020-11-03 | Novocure Gmbh | Reducing motility of cancer cells using tumor treating fields (TTFields) |
| AU2017289870B2 (en) | 2016-06-30 | 2021-12-23 | Novocure Gmbh | Arrays for longitudinal delivery of TTFields to a body |
| CA2972699A1 (en) * | 2016-07-10 | 2018-01-10 | Novocure Limited | Synchronizing tumor cells to the g2/m phase using ttfields combined with taxane or other anti-microtubule agents |
| KR102629400B1 (ko) | 2016-08-18 | 2024-01-24 | 노보큐어 리미티드 | 종양치료장을 전달하기 위한 어레이들 내의 온도 측정 |
| US11109773B2 (en) | 2016-12-13 | 2021-09-07 | Novocure Gmbh | Treating patients with TTFields with the electrode positions optimized using deformable templates |
| WO2018134733A1 (en) | 2017-01-19 | 2018-07-26 | Moshe Giladi | System for viewing cell cultures under a microscope whilst applying ttfields |
| US10369077B2 (en) * | 2017-05-31 | 2019-08-06 | Adienne Pharma & Biotech Sa | Multi chamber flexible bag and methods of using the same |
| GB2567613A (en) * | 2017-06-16 | 2019-04-24 | Argenx Bvba | Treatment for acute myeloid leukaemia |
| TWI676483B (zh) * | 2017-08-06 | 2019-11-11 | 強普生技股份有限公司 | 醫藥套組及其用途 |
| US11298422B2 (en) | 2018-04-09 | 2022-04-12 | Novocure Gmbh | Treating tumors with TTFields and an aurora kinase inhibitor |
| PL3775956T3 (pl) | 2018-04-10 | 2022-10-10 | Novocure Gmbh | Szacunki przewodności ac o niskiej częstotliwości (< 1 mhz) pozyskane z dwóch obrazów mri o różnych czasach repetycji |
| CN116603165A (zh) | 2018-07-03 | 2023-08-18 | 斯坦福大学托管董事会 | 使用交变电场提高细胞膜通透性 |
| US11179322B2 (en) | 2018-07-10 | 2021-11-23 | Novocure Gmbh | Methods and compositions for treating tumors with TTFields and sorafenib |
| MX2020013431A (es) | 2018-07-18 | 2021-05-27 | Novocure Gmbh | Uso de densidad de perdida de potencia y mediciones relacionadas para cuantificar la dosis de campos de tratamiento de tumores (ttfield). |
| KR20250069692A (ko) | 2018-08-23 | 2025-05-19 | 카스텐 하게만 | 뇌-혈액 장벽 투과성을 향상시키기 위한 교번 전기장의 이용 |
| US11160977B2 (en) | 2018-09-04 | 2021-11-02 | Novocure Gmbh | Delivering tumor treating fields (TTFields) to the infratentorial brain |
| CN112770806B (zh) | 2018-09-07 | 2025-12-05 | 诺沃库勒有限责任公司 | 使用交变电场治疗自身免疫性疾病以减少t细胞的增殖 |
| US20200108031A1 (en) | 2018-10-05 | 2020-04-09 | Novocure Gmbh | Treating Tumors Using TTFields Combined with ABT-751 |
| CN113164525B (zh) | 2018-10-23 | 2025-03-14 | 利兰·斯坦福青年大学托管委员会 | 在基于干细胞的疗法中使用交变电场预防和治疗畸胎瘤形成 |
| US11369790B2 (en) | 2018-10-25 | 2022-06-28 | Novocure Gmbh | Delivering alternating electric fields (e.g., TTFields) to a subject's spinal anatomy |
| US20200146586A1 (en) | 2018-11-14 | 2020-05-14 | Novocure Gmbh | Creating Accurate Computational Head Models of Patients Using Datasets Combining MRI and CT Images |
| KR102747887B1 (ko) | 2018-11-19 | 2024-12-27 | 노보큐어 게엠베하 | 선택적으로 주소 지정 가능한 하위 요소를 하지는 종양 치료장 제공을 위한 어레이 |
| SG11202101810SA (en) | 2018-11-29 | 2021-03-30 | Novocure Gmbh | Enhanced-flexibility transducer arrays for delivering ttfields (tumor treating fields) |
| CN113330485B (zh) | 2019-01-08 | 2025-09-26 | 诺沃库勒有限责任公司 | 评估将图像分割成不同类型组织的质量，用于使用肿瘤治疗场（TTField）来计划治疗 |
-
2020
- 2020-03-27 EP EP21208101.2A patent/EP3988099B1/en active Active
- 2020-03-27 PL PL20717971.4T patent/PL3946322T3/pl unknown
- 2020-03-27 EP EP21208102.0A patent/EP3977991A1/en not_active Withdrawn
- 2020-03-27 CN CN202080026046.4A patent/CN113613651B/zh active Active
- 2020-03-27 DK DK20717971.4T patent/DK3946322T3/da active
- 2020-03-27 WO PCT/IB2020/052959 patent/WO2020201967A1/en not_active Ceased
- 2020-03-27 JP JP2021554764A patent/JP7419391B2/ja active Active
- 2020-03-27 EP EP20717971.4A patent/EP3946322B1/en active Active
- 2020-03-27 US US16/832,572 patent/US11911610B2/en active Active
-
2023
- 2023-10-04 JP JP2023172824A patent/JP7714612B2/ja active Active
-
2024
- 2024-01-31 US US18/428,639 patent/US20240350799A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022524824A (ja) | 2022-05-10 |
| CN113613651B (zh) | 2025-08-12 |
| EP3988099C0 (en) | 2023-06-07 |
| DK3946322T3 (da) | 2023-11-27 |
| CN113613651A (zh) | 2021-11-05 |
| US20200306531A1 (en) | 2020-10-01 |
| EP3988099A1 (en) | 2022-04-27 |
| EP3946322B1 (en) | 2023-09-20 |
| EP3946322A1 (en) | 2022-02-09 |
| EP3977991A1 (en) | 2022-04-06 |
| US20240350799A1 (en) | 2024-10-24 |
| WO2020201967A1 (en) | 2020-10-08 |
| JP7714612B2 (ja) | 2025-07-29 |
| EP3988099B1 (en) | 2023-06-07 |
| JP2023171933A (ja) | 2023-12-05 |
| JP7419391B2 (ja) | 2024-01-22 |
| US11911610B2 (en) | 2024-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3946322T3 (pl) | Sposoby przywracania wrażliwości na ttfields w komórkach nowotworowych opornych wobec ttfields, z inhibitorami ptger3 | |
| GB201917183D0 (en) | Battery swelling detection | |
| EP3480321B8 (en) | Massively parallel single cell analysis | |
| EP2943591A4 (en) | METHOD AND COMPOSITIONS FOR PROFILING SINGLE CELL EXPRESSION | |
| IN2015DN00143A (pl) | ||
| EP3014664A4 (en) | PHOTOVOLTAIC CELL AND LAMINATE METALLIZATION | |
| EP3192112A4 (en) | Protective layers in lithium-ion electrochemical cells and associated electrodes and methods | |
| PL3100524T3 (pl) | Pomiary pomocnicze w małych komórkach ze schematem wł./wył. | |
| IL246083A0 (en) | A barrier inhibitor and a whole mycobacterium cell, for use in cancer treatment | |
| EP3075009A4 (en) | Structures and methods with reduced sensitivity to surface charge | |
| EP2968549A4 (en) | CELL CULTURE METHOD | |
| PL3044323T3 (pl) | Sposoby wykrywania i ilościowego oznaczania białka komórki gospodarza w liniach komórkowych | |
| EP3198670A4 (en) | Electrochemical cell with protected negative electrode | |
| GB201417240D0 (en) | Solar cell with specific front surface electrode design | |
| EP3007233A4 (en) | Back-contact-type solar cell | |
| GB201318262D0 (en) | Sram Cells | |
| EP3088526A4 (en) | Use of mirna-214 inhibitor in inhibiting regulatory t cells | |
| EP3335245A4 (en) | SINTERABLE COMPOSITION FOR USE IN PHOTOVOLTAIC SOLAR CELLS | |
| EP3294334A4 (en) | Autoimmune antibodies for use in inhibiting cancer cell growth | |
| EP3235011A4 (en) | Thick damage buffer for foil-based metallization of solar cells | |
| EP3125341A4 (en) | Lead storage cell and electrode collector for lead storage cell | |
| EP3047275A4 (en) | Compositions and methods for increasing mesenchymal stromal cell migration to tumors | |
| PL3475359T3 (pl) | Hydrolitycznie stabilne kompozycje do folii w ogniwach słonecznych | |
| FR3007201B1 (fr) | Cellule solaire multi-jonctions | |
| EP3259782A4 (en) | Damage buffer for solar cell metallization |